GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handok Inc (XKRX:002390) » Definitions » Capital Expenditure

Handok (XKRX:002390) Capital Expenditure : ₩-17,773.41 Mil (TTM As of Mar. 2025)


View and export this data going back to 1976. Start your Free Trial

What is Handok Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Handok's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-3,078 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-17,773.41 Mil.


Handok Capital Expenditure Historical Data

The historical data trend for Handok's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handok Capital Expenditure Chart

Handok Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22,666.75 -43,458.94 -43,738.80 -26,176.24 -19,399.68

Handok Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,704.50 -3,440.53 -7,042.97 -4,211.67 -3,078.23

Handok Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-17,773.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Handok Business Description

Traded in Other Exchanges
N/A
Address
132 Teheran Street, Gangnam-gu, Seoul, KOR, 06235
Handok Inc is engaged in the healthcare sector. It is one of the leading pharmaceutical companies in Korea involved in the development of prescription drugs and OTC drugs, medical devices and in-vitro diagnostics. Its products address major diseases such as diabetes, hypertension and cardiovascular diseases.

Handok Headlines

No Headlines